Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
13%
Ph not_applicable
7
88%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (12.5%)
N/A7 (87.5%)

Trials by Status

recruiting225%
completed675%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8